RCC-JF Cells
Product number:
300274
General information
| Description | Established from the kidney clear cell carcinoma pT2, pM1, No/GII-III of a 65-years-old female, 1999 |
|---|---|
| Organism | Human |
| Tissue | Kidney |
| Disease | Clear cell renal cell carcinoma |
| Synonyms | KTCTL-140, KTCTL140, RCCJF |
Characteristics
| Age | 65 years |
|---|---|
| Gender | Female |
| Ethnicity | Caucasian |
| Morphology | Epithelial-like |
| Growth properties | Monolayer, adherent |
Regulatory Data
| Citation | RCC-JF (Cytion catalog number 300274) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_5879 |
Biomolecular Data
| Protein expression | IL8 |
|---|---|
| Mutational profile | IL8 RS1126647 3-UTR SNP T>T |
Handling
| Culture Medium | McCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a) |
|---|---|
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Split ratio | A ratio of 1:2 to 1:3 is recommended |
| Fluid renewal | 1 to 2 times per week |
| Freeze medium | As a cryopreservation medium, use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|---|
| STR profile |
Amelogenin: x,x
CSF1PO: 10,13
D13S317: 11,12
D16S539: 11
D5S818: 11
D7S820: 7,8
TH01: 07. Sep
TPOX: 8
vWA: 18
D3S1358: 17
D21S11: 28,30.2
D18S51: 13,15
Penta E: 7,13
Penta D: 10,13
D8S1179: 12,14
FGA: 18,25
|
| HLA alleles |
A*: '03:01:01
B*: '37:01:01, '51:01:01
C*: '06:02:01, '07:02:01
DRB1*: '11:01:01, '15:01:01G
DQA1*: '01:02:01, '05:05:01
DQB1*: '03:01:01, '06:02:01
DPB1*: '04:01:01, '13:01:01
E: '01:01:01
|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300274-618 | Certificate of Analysis | 23. May. 2025 | 300274 |